Expression Table for this CRE
| CNhs12080 | Meningeal Cells, donor2 | 2.2 |
| CNhs14133 | Fibroblast - Gingival, donor8 (control) | 1.4 |
| CNhs13330 | Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3) | 1.4 |
| CNhs12059 | Fibroblast - Dermal, donor6 | 1.4 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 1.3 |
| CNhs12852 | submaxillary gland, adult | 1.3 |
| CNhi10939_ACC | Human primary dermal lymphatic vascular endothelial cells, biol_rep1 | 1.3 |
| CNhs13207 | CD14-CD16+ Monocytes, donor2 | 1.2 |
| CNhs11992 | Synoviocyte, donor2 | 1.2 |
| CNhs12866 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6) | 1.2 |
| CNhs13157 | Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1) | 1.1 |
| CNhs12074 | Renal Glomerular Endothelial Cells, donor1 | 1.1 |
| CNhs13646 | Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 1.0 |
| CNhs12822 | H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0) | 1.0 |
| CNhs12474 | K562 erythroblastic leukemia response to hemin, day04, biol_rep1 | 1.0 |
| CNhs12730 | Mesenchymal Stem Cells - hepatic, donor2 | 1.0 |
| CNhs13176 | Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3) | 1.0 |
| CNhs13493 | CD14+ monocytes - treated with Salmonella, donor3 | 0.9 |
| CNhs14601 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 0.9 |
| CNhs13067 | mesothelioma cell line:Mero-41 | 0.9 |
| CNhs14244 | carcinoid cell line:NCI-H727 | 0.9 |
| CNhs12862 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 0.9 |
| CNhs12860 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1) | 0.8 |
| CNhs12545 | CD133+ stem cells - cord blood derived, pool1 | 0.8 |
| CNhs12856 | heart - pulmonic valve, adult | 0.8 |
| CNhs12586 | Oligodendrocyte - precursors, donor1 | 0.8 |
| CNhs14603 | Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 0.7 |
| CNhs14591 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 0.7 |
| CNhs14139 | thymic carcinoma cell line:Ty-82 | 0.7 |
| CNhs12520 | promyelocytes/myelocytes PMC, donor1 | 0.7 |
| CNhs11955 | CD4+ T Cells, donor2 | 0.7 |
| CNhs12828 | H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6) | 0.7 |
| CNhs13378 | Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 0.7 |
| CNhs12016 | Small Airway Epithelial Cells, donor3 | 0.6 |
| CNhs14609 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 0.6 |
| CNhs12007 | Smooth Muscle Cells - Colonic, donor3 | 0.6 |
| CNhs12398 | Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 0.6 |
| CNhs13062 | mesothelioma cell line:NCI-H226 | 0.6 |
| CNhs14483 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2 | 0.6 |
| CNhs12877 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1) | 0.5 |
| CNhs13497 | Hep-2 cells treated with Streptococci strain 5448, biol_rep3 | 0.5 |
| CNhs14611 | Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3 | 0.5 |
| CNhs11999 | CD8+ T Cells, donor3 | 0.5 |
| CNhs13719 | HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2 | 0.5 |
| CNhs12548 | Eosinophils, donor2 | 0.5 |
| CNhs13153 | Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1) | 0.5 |
| CNhs12731 | Meningeal Cells, donor3 | 0.5 |
| CNhs14486 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 0.5 |
| CNhs12538 | Mallassez-derived cells, donor1 (MZH3) | 0.5 |
| CNhs12825 | H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0) | 0.5 |